alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

ABEL SANCHEZ LINARES, AKA Abel 

Hernandez, AKA Angel Hernandez, AKA 

Abel Sanchez, AKA Abel Linares Sanchez, 

AKA Angel Sanchez, 

Petitioner, 

 v. 

WILLIAM P. BARR, Attorney General, 

Respondent.

No. 18-73031 

Agency No. A205-311-710 

MEMORANDUM*

On Petition for Review of an Order of the

Board of Immigration Appeals

Submitted February 4, 2020**

Before: FERNANDEZ, SILVERMAN, and TALLMAN, Circuit Judges.

Abel Sanchez Linares, a native and citizen of Mexico, petitions pro se for 

review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to 

reconsider and reopen. Our jurisdiction is governed by 8 U.S.C. § 1252. We 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

FEB 10 2020

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 18-73031 

review for abuse of discretion the denial of a motion to reconsider or reopen. 

Mohammed v. Gonzales, 400 F.3d 785, 791 (9th Cir. 2005). We deny in part and 

dismiss in part the petition for review.

The BIA did not abuse its discretion in denying Sanchez Linares’s motion to 

reconsider because his motion failed to identify any error of fact or law in the 

BIA’s prior decision denying Sanchez Linares’s motion to reopen as untimely. See

8 C.F.R. § 1003.2(b)(1) (requiring identification of factual or legal error in the 

prior decision).

The BIA did not abuse its discretion in denying Sanchez Linares’s second

motion to reopen as untimely because the motion was filed over two years after the 

order of removal became final, see 8 U.S.C. § 1229a(c)(7)(C)(i) (motion to reopen 

must be filed within 90 days of the final order of removal), and Sanchez Linares

has not established that any statutory or regulatory exception applies, see 8 U.S.C. 

§ 1229a(c)(7)(C); 8 C.F.R. § 1003.2(c)(3).

We lack jurisdiction to review the BIA’s determination not to reopen 

proceedings sua sponte. See Mejia-Hernandez v. Holder, 633 F.3d 818, 823-24 

(9th Cir. 2011); cf. Bonilla v. Lynch, 840 F.3d 575, 588 (9th Cir. 2016).

We deny Sanchez Linares’s motion to supplement the record on appeal, and 

we do not consider the extra-record evidence that Sanchez Linares submitted for 

the first time with his opening brief. See Barrientos v. Lynch, 829 F.3d 1064, 
3 18-73031 

1067 n.1 (9th Cir. 2016) (“As a general matter, we cannot consider extra-record 

evidence. We must limit our review of the merits of [the] petition to ‘the 

administrative record on which the order of removal is based.’” (citing 8 U.S.C. 

§ 1252(b)(4)(A))).

PETITION FOR REVIEW DENIED in part; DISMISSED in part.
Exhibit 31.1

                                 CERTIFICATIONS

         I, Douglas P. Rosefsky, certify that:

           1. I have reviewed this quarterly report on Form 10-Q/A of North
Atlantic Holding Company, Inc.;

           2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;

           3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;

           4. The registrant's other certifying officer and I are responsible
for establishing and maintaining disclosure controls and procedures (as defined
in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

           a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

           b) Evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and

           c) Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an
annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and

           5. The registrant's other certifying officer and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of registrant's
board of directors (or persons performing the equivalent functions):

           a) All significant deficiencies and material weaknesses in the design
or operation of internal controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

           b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal control
over financial reporting.


Date: August 19, 2005


/s/ Douglas P. Rosefsky
---------------------------------
Name:    Douglas P. Rosefsky
Title:   Chief Executive Officer
```

[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 360 Engrossed in House (EH)]

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
107th CONGRESS
  2d Session
H. CON. RES. 360

_______________________________________________________________________

                         CONCURRENT RESOLUTION

    Resolved by the House of Representatives (the Senate concurring), 
That when the House adjourns on the legislative day of Wednesday, March 
20, 2002, or Thursday, March 21, 2002, on a motion offered pursuant to 
this concurrent resolution by its Majority Leader or his designee, it 
stand adjourned until 2 p.m. on Tuesday, April 9, 2002, or until 
Members are notified to reassemble pursuant to section 2 of this 
concurrent resolution, whichever occurs first; and that when the Senate 
recesses or adjourns at the close of business on Thursday, March 21, 
2002, Friday, March 22, 2002, or Saturday, March 23, 2002, on a motion 
offered pursuant to this concurrent resolution by its Majority Leader 
or his designee, it stand recessed or adjourned until noon on Monday, 
April 8, 2002, or at such other time on that day as may be specified in 
the motion to recess or adjourn, or until Members are notified to 
reassemble pursuant to section 2 of this concurrent resolution, 
whichever occurs first.
    Sec. 2. The Speaker of the House and the Majority Leader of the 
Senate, acting jointly after consultation with the Minority Leader of 
the House and the Minority Leader of the Senate, shall notify the 
Members of the House and the Senate, respectively, to reassemble at 
such place and time as they may designate whenever, in their opinion, 
the public interest shall warrant it.

            Passed the House of Representatives March 20, 2002.

            Attest:

                                                                 Clerk.
107th CONGRESS

  2d Session

                            H. CON. RES. 360

_______________________________________________________________________

                         CONCURRENT RESOLUTION

Providing for a conditional adjournment of the House of Representatives 
         and a conditional recess or adjournment of the Senate.
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Financial Institutions Examination Council

          - [Docket No. AS12-06]

# AGENCY:

Appraisal Subcommittee of the Federal Financial Institutions Examination Council

# ACTION:

Notice of Meeting

*Description:*                     In accordance with Section 1104(b) of Title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, as amended, notice is hereby given that the Appraisal Subcommittee (ASC) will meet in closed session:                

*Location:*                     OCC—250 E Street SW., Room 8C, Washington, DC 20219.                

*Date:*                     April 11, 2012.                

*Time:*                     Immediately following the ASC open session.                

*Status:*                     Closed.                

*Matters To Be Considered:*

March 14, 2012 minutes—Closed Session.

Preliminary discussion of State Compliance Reviews.

Dated: March 30, 2012.

James R. Park, 

Executive Director.

[FR Doc. 2012-8130 Filed 4-4-12; 8:45 am]

BILLING CODE P
UNITED STATES AIR FORCE COURT OF CRIMINAL APPEALS

UNITED STATES

v.

Senior Airman MICHAEL BURL

United States Air Force

ACM 38433

23 April 2014

Sentence adjudged 18 June 2013 by GCM convened at Keesler Air Force 

Base, Mississippi. Military Judge: Grant L. Kratz.

Approved Sentence: Bad-conduct discharge, confinement for 26 months, 

forfeiture of all pay and allowances, and reduction to E-1.

Appellate Counsel for the Appellant: Captain Jeffrey A. Davis.

Appellate Counsel for the United States: Colonel Don M. Christensen.

Before

ROAN, HELGET, and MARKSTEINER

Appellate Military Judges

This opinion is subject to editorial correction before final release.

PER CURIAM:

The approved findings and sentence are correct in law and fact, and no error 

materially prejudicial to the substantial rights of the appellant occurred. Article 66(c), 

UCMJ, 10 U.S.C. § 866(c); United States v. Reed, 54 M.J. 37, 41 (C.A.A.F. 2000). 

Accordingly, the approved findings and sentence are AFFIRMED.

FOR THE COURT

STEVEN LUCAS

Clerk of the Court
III

106TH CONGRESS

1ST SESSION S. RES. 195

Expressing the sense of the Senate concerning Dr. William Ransom Wood.

IN THE SENATE OF THE UNITED STATES

OCTOBER 4, 1999

Mr. STEVENS (for himself and Mr. MURKOWSKI) submitted the following

resolution; which was considered and agreed to

RESOLUTION

Expressing the sense of the Senate concerning Dr. William

Ransom Wood.

Whereas Dr. William Ransom Wood’s tireless dedication and

wisdom have earned him honorable distinction for his

work in the city of Fairbanks, the State of Alaska, and

the Nation;

Whereas Dr. Wood served his country with distinction in battle during World War II as a captain in the United

States Navy;

Whereas Dr. Wood served the people of Alaska as president

of the University of Alaska, chairman of the American

Cancer Society, vice president of the Alaska Boy Scout

Council, member of the Alaska Business Advisory Council, chairman of the Alaska Heart Association, and numerous other organizations;
2

SRES 195 ATS

Whereas Dr. Wood served the people of Fairbanks as mayor,

chairman of the Fairbanks Community Hospital Foundation, president of Fairbanks Rotary Club, and in many

other capacities;

Whereas the city of Fairbanks, the State of Alaska, and the

Nation continue to benefit from Dr. Wood’s outstanding

leadership and vision;

Whereas Dr. Wood is the executive director of Festival Fairbanks which desires to commemorate the centennial of

Fairbanks, Alaska, with a pedestrian bridge which shall

serve as a reminder to remember and respect the builders

of the twentieth century; and

Whereas it shall also be in Dr. Wood’s words, ‘‘a memorial

to the brave indigenous people. Who came before and

persisted through hardships, generation after generation.

The Centennial Bridge is a tribute to their stamina and

ability to cope with changing times.’’: Now, therefore, be

it

1 Resolved, That the United States Senate urges the

2 Secretary of Transportation Rodney Slater to designate

3 the Fairbanks, Alaska Riverwalk Centennial Bridge com4 munity connector project as the Dr. William Ransom

5 Wood Centennial Bridge.

Æ
**Exhibit 32.2**

 

**Certification of Chief Financial Officer of GFI Group Inc. Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

 

In connection with the Quarterly Report of GFI Group Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James A. Peers, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.                 The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                 The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 10, 2011

 
| /s/   JAMES A. PEERS        |     |
|-----------------------------|----------|
| James   A. Peers            |     |
| *Chief   Financial Officer* | * * |

 

1

----
**EXHIBIT 31.1**

**CERTIFICATION PURSUANT TO SECTION 302OF THE SARBANES-OXLEY ACT OF 2002**

I, Dale B. Smith,certify that:

1.                 I have reviewedthis Quarterly Report on Form 10-Q/A of Mueller Water Products, Inc.;

2.                 Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.                 Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.                 The registrant’sother certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

(a)          Designed such disclosurecontrols and procedures, or caused such disclosure controls and procedures tobe designed under our supervision, to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

(b)         [Reserved]

(c)          Evaluated theeffectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

(d)         Disclosed in this reportany change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter (the registrant’sfourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and

5.                 The registrant’sother certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (orpersons performing the equivalent functions):

(a)          All significantdeficiencies and material weaknesses in the design or operation of internalcontrol over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and reportfinancial information; and

(b)         Any fraud, whether or notmaterial, that involves management or other employees who have a significantrole in the registrant’s internal control over financial reporting.

Date: February 3,2006

|        | /s/ DALE B. SMITH              |
|--------|--------------------------------|
|   | Name: Dale B. Smith            |
|   | Title: Chief Operating Officer |

 

----
Halogenated Alkylaminium

Safety and Handling

【Hazard Codes】

Xi:Irritant;

【Risk Statements】

R36/37/38

【Safety Statements 】

S26;S37/39

【Specification】

It belongs to the following product categories, such as Ammonium Salts, Greener Alternatives: Catalysis, 

Phase Transfer Catalysts and so on.

Physical properties are: (1)ACD/LogP: -2.60; (2)ACD/LogD (pH 5.5): -2.6; (3)ACD/LogD (pH 7.4): -2.6; 

(4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1; (7)ACD/KOC (pH 7.4): 1; (8)#H 

bond acceptors: 1; (9)#Freely Rotating Bonds: 3.

When you are using this chemical, please be cautious about it as the following:

This chemical is irritating to eyes, respiratory system and skin. When you are using it, wear suitable gloves 

and eye/face protection. In case of contact with eyes, rinse immediately with plenty of water and seek 

medical advice.
[Federal Register Volume 77, Number 64 (Tuesday, April 3, 2012)]
[Notices]
[Page 20059]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-8062]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


National Science Board; Sunshine Act Meetings; Notice

    The National Science Board's Committee on Programs and Plans Task 
Force on Unsolicited Mid-Scale Research, pursuant to NSF regulations 
(45 CFR part 614), the National Science Foundation Act, as amended (42 
U.S.C. 1862n-5), and the Government in the Sunshine Act (5 U.S.C. 
552b), hereby gives notice in regard to the scheduling of a 
teleconference for the transaction of National Science Board business 
and other matters specified, as follows:

DATE AND TIME: Monday, April 16, 2012, 1-2 p.m. EDT.

SUBJECT MATTER: (1) Chair's opening remarks; and (2) Discussion of a 
revised draft of the final report of the NSB Task Force on Unsolicited 
Mid-Scale Research.

STATUS: Open.

LOCATION: This meeting will be held by teleconference at the National 
Science Board Office, National Science Foundation, 4201 Wilson Blvd., 
Arlington, VA 22230. A public listening room will be available for this 
teleconference meeting. All visitors must contact the Board Office 
[call 703-292-7000 or send an email message to 
<a href="/cdn-cgi/l/email-protection#f29c93869b9d9c939e81919b979c9197908096b29c8194dc959d84"><span class="__cf_email__" data-cfemail="365857425f5958575a45555f535855535444527658455018515940">[email protected]</span></a>] at least 24 hours prior to the 
teleconference for the public room number and to arrange for a 
visitor's badge. All visitors must report to the NSF visitor desk 
located in the lobby at the 9th and N. Stuart Streets entrance on the 
day of the teleconference to receive a visitor's badge.

UPDATES AND POINT OF CONTACT: Please refer to the National Science 
Board Web site www.nsf.gov/nsb for additional information and schedule 
updates (time, place, subject matter or status of meeting) may be found 
at http://www.nsf.gov/nsb/notices/. Point of contact for this meeting 
is: Matthew B. Wilson, National Science Board Office, 4201 Wilson 
Blvd., Arlington, VA 22230. Telephone: (703) 292-7000.

Ann Bushmiller,
Senior Counsel to the National Science Board.
[FR Doc. 2012-8062 Filed 3-30-12; 11:15 am]
BILLING CODE 7555-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Page 19678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7823]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.

    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Neurodegeneration.
    Date: April 11, 2012.
    Time: 10 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Mary Custer, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435-
1164, <a href="/cdn-cgi/l/email-protection#b0d3c5c3c4d5c2ddf0d3c3c29eded9d89ed7dfc6"><span class="__cf_email__" data-cfemail="197a6c6a6d7c6b74597a6a6b37777071377e766f">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 27, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy
[FR Doc. 2012-7823 Filed 3-30-12; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>